Ryvu Therapeutics SA Sustainability Reports
Ryvu Therapeutics S.A. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapies for oncology.
Sector: Professional & technical services
Country: Poland
Exchange: Warsaw Stock Exchange
LEI: 2594003WO9Q9HHAFL031
FIGI: BBG001VBZ2J5
14 reports from 2014 to 2025
